TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study.

Arnon P Kater et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.